A rapid colorimetric method for the determination of Losartan potassium in bulk and in synthetic mixture for solid dosage form
Authors:
- Rajani GiridharRGRajani Giridhar
- 1 March 2002
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 27 (6) , 861-866
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2000
- A Gradient Reversed Phase High Performance Liquid Chromatography Method for Simultaneous Determination of Hydrochlorothiazide (HCT) and Losartan Potassium (LOS) from Tablets.Analytical Letters, 2000
- Determination of losartan and its degradates in COZAAR® tablets by reversed-phase high-performance thin-layer chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1998
- A radioreceptor assay for the analysis of AT1-receptor antagonistsJournal of Pharmaceutical and Biomedical Analysis, 1998
- HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and ratsJournal of Pharmaceutical and Biomedical Analysis, 1998
- Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysateJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detectionJournal of Pharmaceutical and Biomedical Analysis, 1997
- Simultaneous determination of losartan and active metabolite EXP3174 in rat plasma by HPLC with column switchingChromatographia, 1996
- Angiotensin receptor antagonists: focus on losartanThe Lancet, 1995
- Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1992